Chalmers overhauls tax system as deficit hits billions
Treasurer Jim Chalmers has confirmed a sweeping overhaul of Australia’s tax landscape.
Treasurer Jim Chalmers has confirmed a sweeping overhaul of Australia’s tax landscape.
The Federal Court has awarded the Yindjibarndi people a record-breaking $150.1 million in native title compensation.
Amanda Lynam, chief credit strategist at Goldman Sachs, says the scale of investment in artificial intelligence is forcing corporates to increasingly diversify their funding outside the US. She speaks on Bloomberg Television.
UK government bonds fell as a growing number of Labour Party lawmakers called on their leader, Prime Minister Keir Starmer, to step down following large losses in local elections last week. Bloomberg's Ven Ram breaks down the situation.
Anna Edwards, Guy Johnson, Tom Mackenzie and Mark Cudmore break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."
Larvotto Resources (ASX:LRV) has delivered the first development ore from the Metz underground mine to surface stockpiles.
Boeing CEO Kelly Ortberg is expected to join the US delegation to China and has hinted at a major deal, saying President Donald Trump's visit would be "a meaningful opportunity for us." China is considering a deal for about 500 of the 737 Max jets. Bloomberg's Danny Lee reports.
Bhagwan Marine (ASX:BWN) flagged resilient FY26 earnings guidance of $44.5m–$46.5m EBITDA despite Middle East project delays
Turaco Gold (ASX:TCG) reported high-grade drill hits at its Afema Project in Côte d’Ivoire, boosting resource confidence.
The Australian Taxation Office has launched a stinging challenge against JB Hi-Fi (ASX:JBH).
EV Resources (ASX:EVR) announced a breakthrough at its Los Lirios Project.
Daiichi Sankyo says its underlying business remains strong despite a one time expense and conservative earnings guidance that came in below market expectations. The Japanese drugmaker reported double digit growth and rising revenue, supported by robust demand for its flagship cancer treatments. The company also outlined its medium term outlook, highlighting antibody drug conjugates, research investment and the role of artificial intelligence, even as competition intensifies and currency moves remain a factor. Hiroyuki Okuzawa, President and CEO of Daiichi Sankyo, spoke exclusively with Shery Ahn on Insight with Haslinda Amin about results, strategy and growth priorities.